Carmichael Hill & Associates’s Idexx Laboratories IDXX Stock Holding History

Carmichael Hill & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$50.5K	Hold	100	–	–	0.02%	369
2024 Q2	$48.7K	Hold	100	–	–	0.02%	346
2024 Q1	$54K	Hold	100	–	–	0.02%	338
2023 Q4	$55.5K	Hold	100	–	–	0.02%	328
2023 Q3	$43.7K	Hold	100	–	–	0.02%	355
2023 Q2	$50.2K	Hold	100	–	–	0.02%	332
2023 Q1	$50K	Hold	100	–	–	0.02%	325
2022 Q4	$40.8K	Hold	100	–	–	0.02%	374
2022 Q3	$33K	Hold	100	–	–	0.02%	402
2022 Q2	$35K	Hold	100	–	–	0.02%	390
2022 Q1	$55K	Hold	100	–	–	0.03%	341
2021 Q4	$66K	Hold	100	–	–	0.03%	317
2021 Q3	$62K	Hold	100	–	–	0.03%	314
2021 Q2	$63K	Hold	100	–	–	0.03%	310
2021 Q1	$49K	Hold	100	–	–	0.03%	341
2020 Q4	$50K	Hold	100	–	–	0.03%	318
2020 Q3	$39K	Buy	+100	New	+$37K	0.03%	329

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carmichael Hill & Associates's IDXX Position: Q3 2024 in Review

Carmichael Hill & Associates held its Idexx Laboratories (IDXX) position steady in Q3 2024 at 100 shares worth $50.5K. The position accounts for 0.02% of the portfolio, ranked #369.

Carmichael Hill & Associates first reported a position in IDXX in Q3 2020 and has held it in 17 quarters since. The position peaked at $66K in Q4 2021. 1,115 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

Carmichael Hill & Associates held 100 shares of Idexx Laboratories worth $50.5K as of Q3 2024.
Carmichael Hill & Associates left its Idexx Laboratories share count unchanged in Q3 2024.
Idexx Laboratories made up 0.02% of Carmichael Hill & Associates's portfolio in Q3 2024, its #369 holding.
Carmichael Hill & Associates first reported a position in Idexx Laboratories in Q3 2020 and has held it in 17 quarters since.
Carmichael Hill & Associates's Idexx Laboratories position peaked at $66K in Q4 2021.
1,115 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.